Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1CNS 1

Conditions

Glioblastoma 15Gliosarcoma 13Brain Neoplasms 7Astrocytoma 5Glioma 4Central Nervous System Neoplasms 4Oligodendroglioma 3Pinealoma 2Meningioma 2Medulloblastoma 2Untreated Childhood Medulloblastoma 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Head and Neck Neoplasms 1Glioma, Subependymal 1Ganglioneuroblastoma 1Esthesioneuroblastoma, Olfactory 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Central Nervous System Nongerminomatous Germ Cell Tumor 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 2Mental Status and Dementia Tests 2motexafin gadolinium 1Vincristine 1Temozolomide 1Rituximab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Procarbazine 1Modafinil 1Methotrexate 1Memantine 1Magnetic Resonance Spectroscopy 1Lithium Carbonate 1Lithium 1Donepezil 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Radiotherapy, Conformal × CNS × Clear all
NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡